Same Indication

Nivolumab vs Paroxetine

Nivolumab vs Paroxetine: Overview

This comparison examines the pharmacological differences between Nivolumab and Paroxetine.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Paroxetine: Potent selective serotonin reuptake inhibitor with additional muscarinic and NE reuptake inhibition.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Paroxetine — 21 hours.

Chemical Properties

Molecular Formula: Paroxetine — C19H20FNO3.

Molecular Weight: Paroxetine — 329.3730 g/mol.

Type: Nivolumab — Antibody; Paroxetine — Small molecule.